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Environmental enteric dysfunction (EED) is a syndrome 
of the small intestine that is endemic in children and 
adults across the developing world1. Although it is by 
definition asymptomatic, EED in children is strongly 
associated with growth stunting and poor developmen-
tal outcomes1–4. The syndrome manifests as a global 
disturbance of gut function, leading to impaired intes-
tinal barrier function and poor uptake of nutrients2–4. 
Environmental origins are suspected, but the aetiology 
is still not well understood and the most effective route 
to prevention and treatment remains unclear5,6.
The huge global burden of EED and our poor under-
standing of the disease motivate the discovery of new 
biomarkers for diagnosis and monitoring, and par-
ticularly for evaluating the efficacy of interventions. 
Validating these biomarkers, however, is challenging, 
as the gold standard of endoscopic biopsy and histology 
is too invasive to be used in large-scale research studies 
in children. A potential alternative route is via ‘optical 
biopsy’ techniques, which enable diagnostic information 
to be obtained less invasively. Here, rather than excising 
tissue for subsequent analysis in a laboratory, optical 
probes are used to make measurements on tissue in situ.
In this Consensus Statement, we summarize the cur-
rent state of knowledge of EED and identify the character-
istics that can be measurable by optical biopsy. We then 
review the most relevant optical biopsy techniques, 
including a description of the underlying technologies 
and their potential role in studying EED. We conclude 
with a set of recommendations for further research 
and development in this area, with a view to enabling 
clinical studies.
Methods
This Consensus Statement arose from a horizon scan 
project funded by the Bill and Melinda Gates Foundation 
to investigate potential applications of optical biopsy in 
tackling gut disease in developing countries. The horizon 
scan was undertaken at Imperial College London, UK, 
and most of the co-authors were invited to join the project 
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Abstract | Environmental enteric dysfunction (EED) is a disease of the small intestine affecting 
children and adults in low and middle income countries. Arising as a consequence of repeated 






tests among the general population. This Consensus Statement identifies and reviews the most 
promising candidate optical biopsy technologies for applications in EED, critically assesses them 
against criteria identified for successful deployment in developing world settings, and proposes 
further lines of enquiry. Importantly, many of the techniques discussed could also be adapted to 
monitor the impaired intestinal barrier in other settings such as IBD, autoimmune enteropathies, 
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advisory board on the basis of their extensive experience 
in relevant fields (T.T., W.A.F., T.J.M., P.D., S.L., A.M., 
R.R.-K., G.J.T. and P.K.). Other co-authors were invited 
to contribute as additional experts (L.S.C., C.L. and F.L.), 
based on the recommendations of the advisory board. 
Members of the board and experts met to discuss the 
horizon scan in London, UK, in November 2015 and 
San Francisco, USA, in February 2016. Literature searches 
were performed using Web of Science, as well as through 
the advice of the advisory board and experts. The results 
of the horizon scan are presented in this Consensus 
Statement, which entails a review of EED, a discussion 
of technologies deemed relevant to EED (based on liter-
ature searches and the opinions of the advisory board and 
experts), and a series of recommendations for the future 
application of the rele vant technologies to the study and 
diagnosis of EED. In the Recommendations section, each 
technology has been assessed according to its suitability 
for application to EED and this assessment includes an 
evaluation of the cost, invasiveness and appropriateness 
for developing  countries of each device and/or technique. 
This assessment was performed in a qualitative manner 
based on currently available information (for example, 
the present cost and size of the devices) and the opin-
ions of the authors as to feasible future develop ment. 
Technique suitability for use in developing countries 
was determined in a qualitative manner after consider-
ation of the need for advanced infrastructure and high 
levels of training for either system use or data analysis. 
Probable deployment time scales have also been assigned 
to each technique based on the current states of develop-
ment and the degree of valid ation work that will be 
required before application to EED. These timescales 
have been tentatively defined as short-term (suitable for 
deployment immediately or within ~1 year), medium- 
term (suit able for deployment within ~1–3  years) 
and long-term (suitable for deployment in 3 years or 
more). A technological readiness level (TRL) is also 
reported for each technology and this score is discussed 
further in the Recommendations section.
EED
Before the 1960s, understanding of small intestinal dis-
orders such as coeliac disease had been hindered by the 
difficulty of obtaining biopsy samples. Newly developed 
techniques, such as the Crosby capsule, then began to 
reveal differences between the intestinal  villous morpho-
logy of residents of developed and developing  countries, 
particularly individuals in India and sub-Saharan Africa. 
These changes were to some extent reversible if an 
individ ual moved between regions7. This ‘tropical entero-
pathy’ was later understood to be more closely linked to 
economic conditions than geographical location, and was 
re-termed ‘environmental entero pathy’ or EED, with the 
latter term emphasizing that it is  characterized by a global 
disturbance of gut function7.
EED is associated with a number of undesirable 
developmental outcomes, including poor response to 
vaccines and increased susceptibility to infection8, and 
most strongly with impaired growth velocity and stunt-
ing9,10. It is now thought that EED is an important compo-
nent of the link between poor environmental conditions 
and reduced height, and a cause of the limited success 
of nutritional interventions in overcoming this growth 
deficit in many populations11. Although stunting in itself 
is not particularly harmful to the individual, it is a highly 
visible manifestation of the effect of EED, and corre-
lates with a much wider range of poor socio economic 
outcomes, including poor performance in education, 
reduced income in adulthood and increased fertility1,11–13. 
Earlier diagnosis of EED, even in infants or very young 
children, could enable targeted interventions.
Diagnosis of EED. Definitive diagnosis of EED is 
 currently by endoscopic biopsy and histology, and the 
histopathological features indicative of EED include: 
blunting of villi; increased crypt depth (although some 
cases show a decrease); reduced villus compartment 
surface area; increased cellular infiltrate, predominantly 
lymphocytes and plasma cells; epithelial monolayer 
fragil ity and breaks; tight junction and cell adhesion 
abnormalities; and increased epithelial cell shedding14. 
These features are shown in FIG. 1.
Given the practical and ethical difficulties associated 
with the use of endoscopic biopsy in infants and young 
children, there has been a considerable drive towards 
identification of biomarkers of EED that can be moni-
tored less invasively. The 2015 Technical Meeting on 
EED15,16 established several descriptive domains of EED 
(BOX 1) in addition to the structural changes seen in 
histology, and any practical approach involving optical 
biopsy is likely to target one or more of these features.
Biomarkers for EED. The most commonly employed 
EED biomarker is the lactulose:mannitol (L:M) test, 
used to measure gut absorptive and barrier function17. 
Lactu lose and mannitol are administered orally, and 
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urine samples are subsequently collected for up to 6 h. 
Lactulose — a large disaccharide molecule — is not nor-
mally absorbed by the healthy small intestine. Mannitol, 
on the other hand, is a smaller mono saccharide that 
passes the healthy intestinal barrier and is found in 
urine17. An increased ratio of lactulose to mannitol 
in the urine, determined by liquid chromatography 
and/or mass spectrometry, therefore indicates one 
or both of reduced absorption or impaired intestinal 
 barrier function. However, in practice the results depend 
strongly on the proficiency of those carrying out the test 
and the level of diligence observed in infant dietary fast-
ing and regular urine collections17, and the test does not 
provide the same direct information as histology.
Many other biomarkers have been proposed as 
candi dates to monitor or diagnose EED (comprehensive 
reviews are available elsewhere14,18) and new bio markers 
are constantly being sought, but there is difficulty in 
obtaining a ‘gold standard’ measurement for compari-
son. Two large-scale trials are also currently investigat-
ing the effect of community-level water and sanitary 
health (WASH)19 improvements on factors including 
child-length for age, child development scores and stunt-
ing prevalence (the SHINE trial in Zimbabwe20 and the 
WASH Benefits Trial in Kenya and Bangladesh21). These 
studies will indicate the degree to which sanitary con-
ditions drive EED and stunting, and hence the level of 
prevention that could be expected from widespread 
WASH improvements. Nevertheless, it is not possible to 
directly link sanitation to specific histological features of 
EED given the ethical and practical difficulties associated 
with performing longitudinal studies requiring repeated 
invasive procedures (under sedation) on asymptomatic 
infants and children in a developing world setting. 
Conversely, correlation with long-term developmental 
outcomes is inherently difficult, time-consuming and 
subject to confounding influences.
The potential benefit of optical biopsy therefore lies in 
providing comparable (or superior) information to histo-
logy in a less invasive manner. In the following section 
we highlight technologies with the potential to provide 
real-time diagnostic information in the small intestine. 
We  then propose specific applications in the measure-
ment of the domains of EED, with consideration of the 
practical issues related to deploying these techniques in 
the affected geographical regions. The principal focus is 
on techniques suitable for limited use within research 
studies aiming to identify noninvasive biomarkers or 
treatments, although we also suggest some  potential 
point-of-care tests suitable for more widespread use.
Optical biopsy for the small bowel
Numerous optical biopsy techniques have been reported 
in the literature, but relatively few have been employed in 
the small intestine, and hardly any specifically for EED. 
The optical imaging and spectroscopic techniques 
included below are therefore only those which have 
demonstrated potential for use in this setting, either 
because they can perform measurements relevant to the 
diagnosis of EED or because there is a history of clin-
ical use related to other small bowel conditions, such 
as coeliac disease. For each technology we summarize 
the underlying principles, assess the technological 
 readiness for clinical applications, and identify potential 
 applications in EED.
Endoscopy and capsule endoscopy. Endoscopy is widely 
used to remotely visualize regions of the gastro intestinal 
tract, including the small intestine. Most modern endo-
scopes use incoherent fibre-optic bundles or distal light 
emitting diodes (LEDs) to illuminate the tissue and 
mini ature cameras to capture live video. Alternatively, 
wireless capsule endoscopy22, which provides live 
imaging via an untethered ingested capsule transiting 
the gastrointestinal tract, has been available since the 
early 2000s. This approach is considerably less invasive 
than standard endoscopy, but offers poorer imaging 
 resolution and is  non-steerable.
Although biopsies are required for definitive histo-
pathological diagnoses, endoscopy can resolve mucosal 
structures such as duodenal villi, suggesting that it could 
identify features of EED. Indeed, endoscopic imaging 
Figure 1 | Features of environmental enteric dysfunction. a | Healthy intestine.  
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has been applied to numerous studies of coeliac disease, 
which exhibits similar but more extreme changes in intes-
tinal structure to EED, including scalloped duodenal 
folds, grooves, fissurations and loss of the  finger-shaped 
villi that cover the healthy mucosal surface23.
The contrast of the villous structure can be enhanced 
through techniques including water immersion24, 
high-definition (HD) endoscopy25, chromoendoscopy26, 
narrow band imaging (NBI)27, and other forms of opti-
cal or digital chromoendoscopy such as optimal band 
imaging (OBI)28, providing sensitivities and specificities 
of up to 100% for villous atrophy25. FIGURE 2a–d shows 
the contrast improvement offered by optical chromo-
endoscopy, revealing clear differences between healthy 
and unhealthy villous mucosa. Furthermore, HD endo-
scopy has been applied to preliminary studies of EED in 
adults (FIG. 2e,f), in which it has been shown capable of 
identifying changes in the villous architecture that are 
associated with EED.
Although endoscopic examinations can be performed 
safely in infants29 and even neonates30, this procedure is 
considerably more challenging — and has higher associ-
ated risks — than when undertaken in adults or older 
children31, even when using the thinnest (<6 mm diam-
eter) paediatric endoscopes. For this reason, endoscopy 
in children is almost always performed using either deep 
sedation or anaesthesia (which have their own associated 
risks32). It would therefore be ethically difficult to under-
take such an invasive procedure for research purposes in 
asymptomatic infants who would derive no immediate 
benefit. This issue limits the role of endoscopy to studies 
in adults or in very small groups of infants (for exam-
ple, in children who are undergoing endoscopy and/or 
 sedation for other reasons).
Capsule endoscopy has previously been deployed in 
children to investigate gastrointestinal bleeding, Crohn’s 
disease, coeliac disease and small bowel polyps33. The 
technique is approved by the FDA for use in children 
≥2 years of age34 and safe use has been demonstrated in 
infants as young as 10 months35. Capsules are inherently 
less invasive than standard endoscopes as they move 
through the body via natural motion induced by peri-
stalsis rather than being manually manoeuvred by the 
clinician. Thus, they are less likely to cause damage to 
the intestinal epithelium during use22. Importantly, endo-
scopic placement of the capsule can enable use of capsule 
endoscopy in children who are unable to  swallow the 
device36, although this method would obviate the benefit 
of the non-endoscopic approach to some degree.
A review by Ianiro et al.25 reported the sensitivity 
and specificity of capsule endoscopy for the diagnosis 
of villous damage in patients with coeliac disease as 
70.0–95.2% and 63.6–100% respectively, lower values 
than typical for HD or NBI endoscopy, but nevertheless 
representing good diagnostic accuracy. Villous atro-
phy was indirectly measured via assessment of image 
mosaicism25. Although this approach could be consid-
ered a limitation, it has the benefit of permitting auto-
mated image analysis37 for use in low-resource settings, 
and these quantitative results can be matched to the 
Marsh criteria (a classification based on the presence 
of intraepithelial lymphocytes, crypt hyperplasia and 
villous atrophy38) that are used in conventional histo-
logical diagnosis of coeliac disease37. However, the risk 
of capsule retention is ~1%33,39, a potential complication 
that might need to be mitigated with tethered capsules or 
ingestible radio frequency identification tags for device 
localization40. Additionally, preliminary studies in adults 
would be required to compare capsule measurements 
to standard endoscopic assessments of villous atrophy.
Fluorescence endomicroscopy. Fluorescence endomicro-
scopy provides high resolution images of tissue in vivo 
via flexible probes41,42 and is one of the most widely used 
and clinically validated optical biopsy techniques (FIG. 3). 
Unlike standard or even HD endoscopy, endomicro-
scopy enables direct identification of morphological 
changes in the tissue microstructure following appli-
cation of topical or intravenous fluorescent stains. 
Most clinical studies use optically-sectioning ‘confocal’ 
endomicroscopy, whereby a focused laser spot is scanned 
across the tissue and an image is built up point-by-point. 
Focusing the collected light through a pinhole before the 
detector results in rejection of out-of-focus light and a 
high contrast image41.
Optical fibres are used for light delivery and collec-
tion, and laser scanning is achieved using either a dis-
tal43,44 or proximal45 mechanism. Miniaturized distal 
scanning mechanisms involve rapidly scanning the tip 
of a single fibre in two dimensions, using miniatur-
ised magnetic or piezo actuators (FIG. 3a). By contrast, 
in proximal scanning, conventional 2D scanning mech-
anisms, such as a pair of galvanometer scanners, are 
used externally (FIG. 3b). The scanning pattern is then 
relayed to the tissue via a flexible bundle containing up 
Box 1 | Descriptive domains of environmental enteric dysfunction
Domains as established by the Technical Meeting on environmental enteric dysfunction 
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EED is associated with impaired function of the small intestinal barrier
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Infection-induced inflammation of the small intestine represents an important part 
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Translocation of bacteria from the lumen into the lymphatics and blood stream 
correlates well with stunting, and has the potential to drive severe short term 
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Microbiota changes
While accurate assessment of the gut microbiota composition is challenging, and 
studies are rare in children with EED, profound changes are suspected that could 
induce alterations in the immune system, colonic fermentation, nervous system 
signalling and metabolic activity
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to 30,000 fibres, which acts as an image conduit. Distal 
scanning can provide high resolution images, generally 
at low frame rates, whereas proximal scanning (using the 
fibre imaging bundle to relay the scanning pattern from 
an external system) enables for sub-mm diameter probes 
at the expense of resolution. Importantly, these sub-mm 
proximal scanning probes are compatible with paediatric 
endoscopes, as they can be inserted through the 2 mm 
diameter working channel. The distal scanning approach 
is used by the ISC-1000 (Pentax, Japan), a 5 mm diameter 
endomicroscope integrated into a Pentax endoscope that 
offers an adjustable working distance for 3D imaging, 
although this device is no longer commercially available. 
The proximal scanning method is used in the Cellvizio 
system (Mauna Kea Technologies, France) and several 
variations of this system are now available46–48, with the 
thinnest probe offered by Mauna Kea Technologies 
having an outer diameter of 0.85 mm (REF. 49). Simple 
non-scanning endomicroscopes, using a fibre-bundle 
to flood illuminate the sample and then collect images, 
have also been applied to the gastrointestinal tract50,51 
but not commercialized.
Studies in the small intestine, both for coeliac dis-
ease and EED itself, have shown that both the ISC-1000 
(REF. 52) and the Cellvizio53,54 systems can resolve villous 
structures, the capillary network and both goblet and 
columnar epithelial cells (FIG. 3d,e) when using intra-
venous fluorescein as a contrast agent. Other studies 
have shown that endomicroscopy can diagnose  coeliac 
disease55–58 based on recognition of features relevant 
to EED, such as villous atrophy, crypt hyperplasia and 
lymphocyte infiltration. In particular, Venkatesh et al.58 
reported successful diagnosis of coeliac disease (100% 
sensitivity, 80% specificity) in children as young as 
1.8 years of age. Semi-automated  methods for the detec-
tion and segmentation of villi56 and for the  measurement 
of goblet cell density57 have also been presented.
Fluorescence endomicroscopy also enables obser-
vation of gaps or breaks in the intestinal epithelial 
lining59–61. For patients with IBS60,61 the leakage of intra-
venous fluorescein into the lumen has been visualized in 
real time61, indicating that endomicroscopy can be used 
to monitor dynamic, cellular level changes in gut func-
tion and permeability. In a study of EED in 41 Zambian 
adults using the Pentax ISC-1000 endo microscope4, only 
8 (20%) exhibited no luminal leakage of fluorescein and 
only 2 (5%) showed no fluorescein plumes. By compari-
son, in a healthy population, 80% showed no fluorescein 
leakage or plumes (P < 0.0001)62. Endomicroscopy was 
also used to quantify single and multiple cell defects, cell 
shedding events, apoptotic cells and epithelial break-
down lesions in patients with severe and minimal EED, 
and these features were corre lated to the expression of 
23 genes that were found to be differentially expressed 
in intestinal epithelium4.
Fluorescence endomicroscopy therefore has the 
potential to provide information relevant to EED, 
including structural changes in the small intestine and 
measurements of gut permeability. Although advanced 
systems with 3D imaging capabilities could be particu-
larly useful in early studies, such experiments might 
be restricted by the lack of a commercially available 
instrument. Thus, smaller diameter fibre-bundle-
based systems will probably be more convenient and 
will certainly be most suitable for use in children (due 
to their small size and compatibility with paediat-
ric endoscopes). However, endomicroscopy requires 
use of an endoscope and so is likely to be limited to 
research studies in adults or small groups of children 
(possibly those undergoing endoscopy and/or seda-
tion for alternative reasons). Less invasive imaging 
could be possible using a tethered fluorescence endo-
micro scopy capsule ( similar to the reflectance confocal 
microscopy  capsule63), but a practical system is yet to 
be demonstrated.
Endoscopic optical coherence tomography. Endoscopic 
optical coherence tomography (OCT)64 provides high 
resolution, high speed, cross-sectional images to a 
 tissue depth of 1–2 mm. It is predominantly a structural 
imaging tool, able to visualize the morphology of both 
villi and crypts in the small intestine65. The advantages 
over endomicroscopy are its high speed (allowing rapid 
Figure 2 | Endoscopic imaging of intestinal villi. a | Image illustrating the improved 
villous contrast provided by optimal band imaging (OBI) and high definition (HD) 
endoscopy. b | An equivalent image utilizing HD endoscopy alone. c | Narrow band 
imaging (NBI) of regions of tissue exhibiting healthy villi. d|| NBI images showing regions of 
tissue with absent villi. e | HD endoscopy image recorded in an adult with EED exhibiting 
partial blunting of villi. f | HD endoscopy image in an adult with EED showing subtotal 
villous atrophy. Parts a,b reprinted from Gastrointestinal Endoscopy, 68, Cammarota, G. 
GV|CN27, Optimal band imaging system: a new tool for enhancing the duodenal villous 
pattern in coeliac disease, 352–357, Copyright 2008, with permission from Elsevier. 
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interrogation of large areas of tissue) and the ability to 
obtain cross-sectional images, although it is unable 
to visualize fluorescent dyes.
Detailed descriptions of the principles of OCT are 
available elsewhere (for example REF. 66), but, briefly, it 
involves illuminating tissue with a low coherence light 
source and using interferometry to select (coherence 
gate) light returning from a chosen depth layer. By scan-
ning the position of the coherence gate it is then possible 
to generate a depth scan along the z-axis into tissue (also 
known as an A-scan). Axial resolutions as low as approx-
imately 1 µm are achievable, although 10–20 µm is more 
common for endoscopic systems. Volumetric imaging 
is enabled by lateral scanning in two dimensions (with 
lateral resolutions typically on the order of 10–20 µm)66. 
Modern systems use Fourier domain techniques to 
achieve A-scans at hundreds of kHz or even MHz (REF. 67) 
rates by acquiring data from all depths simultaneously.
OCT is inherently fibre compatible and a wide range 
of endoscopic systems have been developed. The main 
challenge is the fabrication of a high speed  lateral scan-
ning mechanism at the distal tip. A  number of forward 
viewing probes have been reported (for example REF. 68) 
using similar approaches to distal scanning endomicro-
scopes, and although these have been used in the gastro-
intestinal tract (for  example REF. 69), side viewing devices 
are more suited to imaging large areas of lumina. Side 
viewing probes are  readily fabricated by incorporating 
a right angled prism and one or more micro-lenses at 
the distal tip of a fibre. Proximally driven rotation of the 
fibre probe, or rotation of the prism using a micro- motor, 
generates circular cross-sectional images, while pull-back 
of the probe enables collection of volu metric datasets70 
over large regions of tissue. Probes with diameters <1 mm 
are achievable — allowing deployment through either 
standard or paediatric endoscopes and catheters — and 
have been applied extensively to vascular imaging (for 
example REF. 71) and within the  gastrointestinal tract 
(for example REF. 72).
Tethered capsule OCT (also referred to as teth-
ered capsule endomicroscopy, TCE) was reported by 
Gora et al.73 in 2013. The capsule (which measures 
24.8 mm by 12.8 mm) is swallowed by the patient, rather 
than being introduced by endoscope, and provides 3D 
imaging via a pull-back manoeuvre (FIG. 4). This tech-
nology is considerably less invasive than endoscopy, 
as the capsule relies on natural peristalsis to pass through 
the gastrointestinal tract rather than being externally 
manoeuvred, and can be undertaken in unsedated (adult) 
patients73. TCE has been applied to the assessment of 
Barrett oesophagus, with volumetric images of the entire 
oesophagus collected in as little as 60 s (REF. 74). There 
have also been initial reports of extending TCE to rapid, 
minimally invasive imaging of the small intestine75.
Although there have been few in vivo OCT investi-
gations of the small intestine, a 2005 study65 using an 
endoscopic probe-based system demonstrated clear 
visualization of villi. In addition, a subsequent attempt 
Figure 3 | Endomicroscopy for optical intestinal biopsy. a | Distal scanning endomicroscopy. b | Proximal scanning 
endomicroscopy. The proximal scanning approach results in a smaller probe tip that can be used with paediatric 
endoscopes. c | Cellvizio image of the terminal ileum acquired using intravenous fluorescein staining. d |+5%KOCIG
of the duodenal mucosa acquired using intravenous fluorescein staining. e |+5%KOCIGQHVJGUOCNNKPVGUVKPCNOWEQUC
CESWKTGFWUKPIKPVTCXGPQWUHNWQTGUEGKPUVCKPKPIKPCPCFWNVYKVJ''&UJQYKPINGCMCIGQHHNWQTGUEGKPVJTQWIJVJG
epithelium (arrow). f |#EGNNUJGFFKPIGXGPV
CTTQYKPVJGUCOGRCVKGPVCNUQXKUWCNK\GFWUKPIVJG+5%U[UVGO 
Part c reprinted from Gastrointestinal Endoscopy, 776WTEQVVG,(GV|CN60$TGCMUKPVJGYCNNKPETGCUGFICRUKPVJG
intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos), 
624–630, Copyright 2013, with permission from Elsevier. Part d reprinted from Baishideng Publishing Group Inc, 
8GPMCVGUJ-et al.58 World,)CUVTQGPVGTQN15, 2214–2219 (2009). Parts e,f provided by P.K. 
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to diagnose coeliac disease using this technique by 
assessing villous atrophy76 reported a sensitivity and 
specificity of 100% and 82%, respectively, in a group of 
67  children aged 1–14 years. Images from this study are 
shown in FIG. 4c,d.
OCT therefore seems to offer sufficient resolution 
for the assessment of changes in the tissue microstruc-
ture that are relevant to EED. Moreover, tethered cap-
sule OCT systems provide minimally invasive, high 
speed imaging and could be applied to large cohorts of 
adults to obtain an unprecedented level of information 
from large sections of the small intestine. This approach 
could also be extended to children and infants, with 
the risk of capsule retention mitigated by the tether. 
However, endoscopic introducers are probably neces-
sary in young children to aid swallowing of the capsule, 
which might be challenging for large-scale implemen-
tation. Nonetheless, the deployment of TCE in small 
numbers of children could be feasible and could help 
to provide vital information on the changes that occur 
in intestinal tissue microstructure during the early 
stages of development. Interestingly, if smaller capsules 
are desirable for paediatric use then their development 
should be feasible, as the combined diameter of all opti-
cal and mechanical components contained within the 
capsule is already considerably smaller than that of 
the capsule itself (FIG. 4a). For example, 1 mm exter-
nal diameters have been achieved in the side-viewing 
vascu lar or endoscopic OCT probes discussed earlier 
in this section, which use near-identical technology to 
that used in capsule OCT.
Fluorescence and reflectance spectroscopy. Optical 
spectroscopy entails illuminating tissue with light of 
a known wavelength and recording the intensity of 
the returning signal, such as fluorescence or scattered 
Figure 4 | Tethered capsule OCT and OCT-based visualisation of 
intestinal villi. a | A tethered capsule optical coherence tomography (OCT) 
system. PP, polypropylene ball handle. b|^ &XKGYQHVJGGPVKTGQGUQRJCIWU
in a patient with Barrett oesophagus, obtained via 3D rendering of data 
collected as the OCT capsule is withdrawn from the stomach. Distinct 
features are revealed by OCT including normal gastric mucosa (left 
ETQUUUGEVKQPCNKOCIGJKIJITCFGF[URNCUKC
*)&CPFKPVTCOWEQUCN
carcinoma (IMC) (centre), and normal squamous mucosa (right). 
c| ^|2TQDGDCUGF1%6KOCIGEQNNGEVGFKPVJGFWQFGPWO
NGHVCPF




(arrows) exhibiting a flattened mucosal surface, and the corresponding 
histological image (right). Parts a,b adapted with permission from 
Macmillan Publishers Ltd, part of Springer Nature © Gora, M. J.GVCN73, 
0CV|/GF 19, 238–240 (2013). Parts c,d reprinted from Digestive and Liver 
Disease, 41, Masci, E. GV|CN76, Optical coherence tomography in pediatric 
RCVKGPVU#|HGCUKDNGVGEJPKSWGHQTFKCIPQUKPIEQGNKCEFKUGCUGKPEJKNFTGP
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light, as a function of wavelength (these principles are 
described in detail elsewhere77). Although 2D spectral 
imaging is possible, spectroscopic clinical studies often 
involve single point measurements only, sacrificing 
 spatial resolution to achieve acceptable acquisition times 
and to minimise probe complexity.
Although fluorescence and reflectance spectroscopy 
(along with various further spectroscopic techniques) 
have been applied to disease studies in the gastrointes-
tinal tract using fibre-based endoscopic probes, this is 
unlikely to represent the most promising application for 
EED. Endoscopic spectroscopy could certainly be used 
to monitor the metabolic status of the gut via fluores-
cence measurements (for example, of the relative fluo-
rescence intensities or the fluorescence lifetimes of the 
enzymatic cofactors NADH and FAD)78–80. In addition, 
a variety of reflectance-based modalities (including dif-
fuse reflectance spectroscopy81,82 and elastic scattering 
spectroscopy83) could enable assessment of the tissue 
oxygen saturation and the haemoglobin concentration.
It is possible that both metabolic measurements (for 
example of the tissue redox ratio79,80) and quantification 
of the haemoglobin concentration and/or tissue oxygen 
saturation could be relevant to EED, but this applica-
bility is yet to be confirmed experimentally. Another 
potential use of reflectance spectroscopy in EED could 
lie in determining some of the morphological changes 
relevant to the disease, such as the degree of cellular 
infiltration or the prevalence of breaks in the epithe-
lial monolayer. Light scattering spectroscopy84–86 and 
low-coherence enhanced backscattering spectroscopy87 
have both been used to assess aspects of cellular and 
tissue morphology (in vivo in the human oesophagus, 
colon and duodenum) and, as such, it might be pos sible 
to extend these techniques to EED. Fibre-optic fluo-
rescence spectroscopy could also be used to monitor 
the leakage of intravenous fluorescent dye into the gut 
lumen in a similar manner to that described for fluo-
rescence endomicroscopy. In all cases, however, these 
spectro scopic techniques will not provide spatial res-
olution and, for that reason, would be inferior to their 
competitors. Furthermore, although the reduced com-
plexity of single point spectroscopy probes means that 
their outer diameters can often be smaller than those 
of fluorescence endomicroscopes, they still require an 
endoscope for deployment and, hence, can be consid-
ered equally invasive. In addition, endomicroscopy and 
OCT systems are (in some cases) commercially avail-
able and currently have a higher level of clinical pene-
tration than endoscopic spectroscopy devices, implying 
that their deployment for research studies will be  easier. 
Thus, it is likely that endomicroscopy and OCT will 
prove more useful for investigating changes in the mor-
phology and the permeability of intestinal tissue in EED 
than in vivo endoscopic spectroscopy.
An alternative, more promising application of fluo-
rescence spectroscopy in EED could be to monitor gut 
permeability in a minimally invasive or non invasive 
manner from outside of the body, without the use of an 
endoscope. A number of studies have reported the use of 
microscopy or spectroscopy combined with fluo rescent 
or reflective microparticles to monitor intestinal closure, 
transport and translocation in animals88–93. In general, the 
protocols used in these investigations first involved feed-
ing animals a dose of a contrast agent such as fluo rescein 
isothiocyanate (FITC)-labelled dextran88,89, fluores cently 
tagged polystyrene microspheres90,91,  colloidal gold 
nano particles92 or iron oxide nano particles93. The uptake 
of contrast agent from the intestine into the blood, or 
into specific cells or tissues, was then assessed using 
spectroscopy or microscopy. Importantly, whereas many 
of these studies relied upon microscopic examination of 
ex vivo tissue samples to determine the degree of uptake, 
the work by Weström et al.88 and Ekström et al.89 demon-
strated direct monitoring of the blood serum concen-
tration of fluorescein (in ex vivo blood samples) using 
fluorescence  spectroscopy.
Translating this approach into in vivo human use 
could be possible using a number of methodologies 
(FIG. 5), the most promising of which would involve the 
use of fluorescence spectroscopy to make noninvasive 
measurements of gut leakiness. In this scenario, the 
patient would receive an oral dose of contrast agent and 
the concentration of the agent in the blood would be 
measured some time later using a transcutaneous spec-
trometer. Such a device could entail a fingerclip system 
(similar to many commercially available pulse oxime-
ters) or a skin patch. Both could be fabricated at low cost 
Figure 5 | Overview of possible methods for the assessment of gut permeability 
using fluorescence spectroscopy or microscopy of exogenous dyes and 
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and would be almost entirely non invasive. In addition, 
measurements of fluorescent dyes conjugated to parti-
cles of varying sizes would permit semi- automatic quan-
tification of gut permeability. Validation for application 
to EED could be achieved by combining spectral meas-
urements with L:M tests and/or morphological imaging. 
Importantly, after successful validation, transcutaneous 
fluorescence spectroscopy will be suitable for noninva-
sive monitoring of gut perme ability in large cohorts of 
infants for studies such as the  assessment of nutritional 
or WASH interventions.
Photoacoustic imaging. Photoacoustic imaging (PAI) 
— which relies upon the photo-acoustic effect, whereby 
a material absorbing light emits acoustic waves94 — 
involves exciting tissue with nonionizing laser pulses. 
When absorbed by chromophores in the tissue, this 
excitation generates heat, expansion of material and 
subsequent emission of ultrasound that can be detected 
with an ultrasonic transducer95,96. Both endogenous 
chromophores, such as oxyhaemoglobin and deoxy-
haemoglobin, and exogenous contrast agents can 
be used, enabling PAI to provide multifaceted data 
 containing both structural and functional information.
As this technology is based upon the detection of 
ultrasonic pressure waves, PAI affords considerably 
higher tissue penetration depths than other optical 
imaging modalities. There is a trade-off between pene-
tration depth and resolution, but sub-mm resolution 
is achievable at depths of up to a few cm (REF. 96). 
Penetration of a few cm would be sufficient to image the 
intestine of an infant from outside of the body, and so 
PAI might provide another route towards noninvasive 
investigation of EED, although this application remains 
highly speculative.
Although numerous chromophores (endogenous 
or exogenous) can be imaged using PAI, a probable 
application to EED is in imaging of gut permeability. 
This procedure would require the use of exogenous con-
trast agents and would entail protocols similar to those 
described earlier for fluorescence spectroscopy. One 
approach would involve imaging the leakage of an intra-
venously delivered photoacoustic contrast agent from 
the blood stream into the gut using endoscopic probes. 
Several endoscopic PAI probes have been reported97 
and a number have been applied to gastrointestinal 
studies, both in live animals98 and in ex vivo samples 
of human tissue99, suggesting that this technique would 
be entirely feasible. Alternatively, non invasive PAI 
could be achieved by using an orally ingested contrast 
agent along with an external imaging probe (likely to 
consist of a pulsed excitation laser combined with a 
commer cially available ultrasound transducer similar 
to the devices reported in REF. 100 and REF. 101). Unlike 
transcutaneous fluorescence spectroscopy, PAI could 
permit spatial mapping of the leakiness of the intes-
tine, hence offering a more detailed assessment of the 
perme ability of the gut. Although PAI using an exter-
nal imaging probe could potentially be applicable to 
large scale studies in children (due to its noninvasive 
nature), it is an immature technology and substantial 
developmental work will be necessary, for example 
in combining PAI with other measurement protocols 
for validation. Nonetheless, due to the potential util-
ity for EED, this development and validation is likely 
to be worthwhile.
Recommendations
Although each of the techniques described above has 
potential applications in EED, they differ not only in 
terms of their format, the information they provide, 
and the type and scale of study they will be most appro-
priate for, but also in their technological maturity. The 
TRLs of each technology are listed in TABLE 1, along 
with additional information including the expected 
development timescales. The TRL scale (adapted from 
a scale originally developed by NASA) ranges from 1 
to 9, with ‘1’ indicating an initial concept and ‘9’ repre-
senting a mature, commercialized device102. Other 
 factors rele vant to the adoption of these techniques for 
EED are also listed, including cost, invasiveness and 
suitability for developing world use. These additional 
factors are particu larly important for large scale stud-
ies (given issues that can be expected at scale, such as 
the need for widespread deployment and the analy-
sis of large datasets), although less-so for early aetio-
logical investigations in small groups of patients. The 
likelihood of a technology finding other uses in more 
developed healthcare systems is also a consideration, 
as this affects the chances of subsequent commercial 
investment, as well as providing additional routes for 
testing and validation.
As can be seen from the TRLs in TABLE 1, the time-
scale over which techniques could be applied to EED 
varies markedly. HD and NBI endoscopy and endo-
microscopy both have high TRLs, being fully commer-
cialized and widely deployed, and could be adopted for 
use in EED immediately. Both have the potential to prov-
ide vital new information on the structural changes that 
occur in the gut as a result of EED, and endo microscopy 
has already been applied to the study of both gut struc-
ture and permeability in adults with EED4. Endoscopy 
and endomicroscopy could be applied in the short term 
to small-scale aetiological investigations, most practi-
cably in cases where children are already undergoing 
 sedation for other procedures (given the invasiveness of 
the proposed measurements).
Capsule endoscopy could also be used immediately, 
although some validation (for example, comparison to 
endoscopy or endomicroscopy) will be required in order 
to confirm the sensitivity and specificity of the tech-
nique in detecting villous atrophy. Subsequently, capsule 
endoscopy could be applied to studies in large cohorts as 
the procedure is considerably less invasive than standard 
endoscopy. Detection of villous atrophy can be achieved 
using automated image processing algorithms, remov-
ing the requirement for manual analysis by a specially 
trained pathologist. Although it is only approved for 
children older than 2 years of age, endoscopic introduc-
tion would enable capsule imaging in younger children 
and the development of smaller devices could allow this 
restriction to be challenged.
C O N S E N S U S  S TAT E M E N T
NATURE REVIEWS | GASTROENTEROLOGY & HEPATOLOGY  ADVANCE ONLINE PUBLICATION | 9
A?ɥA?A?A?A?ɥ!,(++-ɥ4 +(2'#12ɥ(,(3#"A?ɥ/13ɥ.$ɥ/1(-%#1ɥ341#A?ɥ++ɥ 1(%'32ɥ 1#2#15#"A? A?ɥA?A?A?A?ɥ!,(++-ɥ4 +(2'#12ɥ(,(3#"A?ɥ/13ɥ.$ɥ/1(-%#1ɥ341#A?ɥ++ɥ 1(%'32ɥ 1#2#15#"A?
Transcutaneous fluorescence spectroscopy and teth-
ered capsule OCT are both suitable for medium-term 
use (within ~1–3 years). Tethered capsule OCT has 
already been shown to enable imaging of the entire 
oesophageal mucosa in a matter of minutes using a pro-
tocol that is considerably less invasive than endoscopy. 
Moreover, OCT is capable of resolving intestinal villi, 
making it a very promising tool for the investigation 
of EED due to its capability to evaluate many villi in 
one procedure. Further development will be required 
to  enable intestinal imaging but this should not be a 
limiting factor. As with capsule endoscopy, use of OCT 
in children is feasible but will be limited to those aged 
2 years and above. Again, this constraint can be mitigated 
by further miniaturiza tion and the incorporation of 
endoscopic introducers into experimental protocols.
Fluorescence spectroscopy is also a promising tech-
nology due to its potential to be applied almost non-
invasively. Fingerclip-style spectrometers could be used 
to monitor the leakage of orally administered contrast 
agents from the gut to the blood stream, prov iding func-
tional information pertinent to EED. This approach will 
require validation, either using some of the high-TRL 
imaging instruments discussed  earlier or L:M tests. 
Once this validation is complete, fluorescence spectro-
scopy will be applicable to large-scale studies in remote 
locations due to its practically noninvasive methodology, 
low cost, simplicity of data analysis and ease of deploy-
ment. Interestingly, there might be scope to extend this 
approach for use with multiple molecu lar probes to 
 evaluate further aspects of intestinal pathophysiology.
Finally, PAI could in the future also offer a non-
invasive experimental protocol for the assessment of 
gut permeability (similar to that described for fluores-
cence spectroscopy), with an external PAI probe used 
to image the small intestine from outside of the body. 
An advantage over spectroscopy could be the ability to 
obtain low-resolution spatial maps of gut permeability, 
although more advanced data analysis will be required 
(possibly necessitating a pathologist). Substantial 
research and development work is needed, both in 
device design and validation, meaning that PAI would 
only be deployable in the longer term (>3 years).
The list of optical biopsy techniques presented 
herein is not exhaustive and other approaches might 
be useful in the study of EED. One example is Raman 
spectro scopy, which has been used for the detection 
and identifi cation of bacteria in previous investiga-
tions103,104 and could prove useful in establishing the 
make-up of the intestinal microbiota (for example, via 
measurements of tissue or faecal samples, or through 
in vivo endoscopic studies). Endocytoscopy, a form of 
white light endomicroscopy, can also visual ize  normal 
villi105, but cannot detect the functional changes visual-
ized by fluorescence endomicro scopy. There is also a 
range of both optical and nonoptical (typically electro-
chemical) sensing techniques that enable simultane-
ous and selective measurements of metabolite (for 
example, lactate, glucose), electrolyte (for example, 
pH, sodium, potassi um) or other biomarker concen-
trations in a  variety of samples (such as blood,  tissue, 
urine, saliva and sweat, for example in REF. 106). These 
approaches could have uses, for example, in the detec-
tion of cytokines or other markers of inflammation that 
are relevant to EED. Indeed, some of these approaches 
(in particular electro chemical sensing and Raman 
spectroscopy) might complement the optical biopsy 
techniques discussed in this article, as they have the 
potential to provide measurements that are not  possible 
with the methods highlighted here. For example, 
investigating the intestinal microbiome using Raman 
spectroscopy and assessing gene expression through 
electrochemical detection of specific biomarkers 
could both hold substantial merit in the study of EED. 
As such, all of the above techniques could be  worthy of 
further investigation.
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Technological readiness level (TRL) is a scale indicating the maturity of a technology. A score of ‘1’ represents an initial concept, whereas a TRL of ‘9’ indicates a 
mature, commercialised technology. The remaining factors have been determined in a qualitative manner as described in the Methods section. Deployment 
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Conclusions
EED is a widespread condition in developing countries, 
in some cases affecting almost entire regional popula-
tions, and has severe negative impacts on the physical 
and cognitive development of children. Given that EED 
remains poorly understood, it is vital that new tech-
nologies and approaches are investigated and imple-
mented to improve understanding of the disease and to 
help guide the development of new therapies. We have 
identified and assessed optical biopsy techniques with 
potential to assist in this area. Although many optical 
methodologies could potentially be applied, we have 
highlighted endoscopy (including HD, NBI and capsule 
endoscopy), fluorescence endomicroscopy, OCT, fluo-
rescence spectroscopy and PAI as the most promising. 
These will provide data not only on structural changes 
in the intestine, but also on the degree of intestinal 
permeability. We have identified how each approach 
could be advanced towards this goal, and we expect 
each technique to offer important and unique informa-
tion. The further investigation and development of all 
of these approaches could result in a pipeline of stud-
ies offering rich and varied information on this poorly 
understood disease.
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